[1]中华医学会.慢性乙型肝炎防治指南[J].中华传染病杂志, 2005, 23 (6) :421-431.
|
[2]田瑛, 邱志峰, 李太生.慢性乙型肝炎患者和乙型肝炎病毒携带者外周血T细胞亚群的变化和意义[J].中华医学杂志, 2005, 85 (47) :3354-3358.
|
[3]冯慧芬, 张淑凤.慢性HBV感染者外周血淋巴细胞亚群的特征性研究[J].医药论坛杂志, 2007, 28 (6) :32-33.
|
[4]杜美华, 高涛, 王介非.从淋巴细胞亚群绝对值探讨慢性乙型肝炎细胞免疫[J].Chinese Hepatology, 2006, 11 (4) :260-261.
|
[5]Guidotti LG, Rochford R, Chung J, et al.Viral clearance without destruction of infected cells during acute HBV infection[J].Sci-ence, 1999, 284 (5415) :825-829.
|
[6]李乐, 蔡鹏威, 伍严安, 等.慢性乙肝病毒携带者的细胞免疫功能变化及其与血清HBV DNA的关系[J].福建医药杂志, 2003, 25 (6) :18-20.
|
[7]Acuto O, Michel E.CD28-mediated co-stimulation a quantitative support for TCR signalling[J].Nat Rev Immunol, 2003, 3 (12) :939-951.
|
[8]Susanne B, Vito R, Cicinnati, et al.Hepatitis B virus-Induce de-fect of monocyter derived dendritic cells leads to impaired T helper type1response in vitro:mechanisms for viral immune escape[J].Immunology, 2003, 109 (4) :487~495.
|
[9]Appleman L J, Boussiotis V A.Tcell anergy and costimulation[J].Immunol Rev, 2003, 192 (4) :161-180.
|
[1] | Li CaiDong, Chen XiLian, Tian PengFei, Li HuiJun, Wu Bin. Correlation analysis of percentages of T lymphocyte subsets and CD4~+CD25~+ regulatory T cells and HBV DNA level in peripheral blood of chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2015, 31(4): 541-545. doi: 10.3969/j.issn.1001-5256.2015.04.016 |
[2] | Li CaiDong, Wu Bin, Chen XiLian, Tian PengFei, Duan ZhengJun. Changes in peripheral blood T cell subsets and TGFβ and their clinical significance among HBV infection patients with different viral loads[J]. Journal of Clinical Hepatology, 2014, 30(9): 882-886. doi: 10.3969/j.issn.1001-5256.2014.09.011 |
[3] | Wang Wei, Zheng HuanWei, Ren GuiFang, Feng AiDong, Liu Lian, Li BingShun. Differential profiles of T-cell subsets are present in peripheral blood of patients with various progressive forms of hepatitis B infection[J]. Journal of Clinical Hepatology, 2013, 29(4): 276-279. |
[4] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
[5] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[7] | Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18. |
[11] | Xu QingXia, Guan Dong, Chen GuangYi, Li HongMin. Investigation on HBV and HCV infection among people of HCC, other malignant tumor and health.[J]. Journal of Clinical Hepatology, 2004, 20(2): 104-105. |
[12] | Zhao Wei, Wan JianMin, Liu Wei, Liu QuanJun, Zhang Lin, Zhang HanRong, Liu XinYu, Zhou ZhenXian. Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array[J]. Journal of Clinical Hepatology, 2003, 19(3): 178-180. |
[13] | Yang SiLin. To survey influence degree of father and mother HBV arrier on next generation HBV infections rate.[J]. Journal of Clinical Hepatology, 2002, 18(6): 350-351. |
[14] | Xin YongNing, Sun Ying, Zhang Jian, Lu: WeiHong, Zhang Mei, Chu LeiLei, Li Ning, Sun ZhenJuan. The study of the influence of lamivudine to T-Lymphocyte-subsetes of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(3): 192-193. |